2015 Analysis of Emerging Infectious Disease Tests, and Strategic Profiles of Leading Suppliers

January 2015 | 760 pages | ID: 2B919F54781EN
Venture Planning Group

Abstracts

This 760-page report presents a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 100 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 760 pages and 31 tables

Contents

1. Worldwide Business Environment

2. Worldwide Market Structure

3. Worldwide Market Size and Growth

4. Competitive Assessments

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
GenProbe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List Of Tables

LIST OF TABLES

Table 1: Laboratories Performing Infectious Disease Tests by Country
Table 2: Infectious Disease Test Volume Forecasts by Country
Table 3: Infectious Disease Diagnostics Market Forecasts by Country